LPL Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $517K | Buy |
61,011
+16,311
| +36% | +$138K | ﹤0.01% | 4291 |
|
|
2025
Q1 | $359K | Sell |
44,700
-1,900
| -4% | -$15.3K | ﹤0.01% | 4369 |
|
|
2024
Q4 | $418K | Buy |
46,600
+8,327
| +22% | +$74.8K | ﹤0.01% | 4173 |
|
|
2024
Q3 | $281K | Buy |
38,273
+2,091
| +6% | +$15.3K | ﹤0.01% | 4400 |
|
|
2024
Q2 | $207K | Buy |
36,182
+3,175
| +10% | +$18.1K | ﹤0.01% | 4451 |
|
|
2024
Q1 | $165K | Sell |
33,007
-210
| -0.6% | -$1.05K | ﹤0.01% | 4474 |
|
|
2023
Q4 | $299K | Buy |
33,217
+600
| +2% | +$5.39K | ﹤0.01% | 4034 |
|
|
2023
Q3 | $253K | Buy |
32,617
+2,900
| +10% | +$22.5K | ﹤0.01% | 4015 |
|
|
2023
Q2 | $288K | Buy |
29,717
+4,809
| +19% | +$46.6K | ﹤0.01% | 3839 |
|
|
2023
Q1 | $273K | Sell |
24,908
-431
| -2% | -$4.72K | ﹤0.01% | 3790 |
|
|
2022
Q4 | $109K | Sell |
25,339
-781
| -3% | -$3.37K | ﹤0.01% | 4119 |
|
|
2022
Q3 | $196K | Sell |
26,120
-423
| -2% | -$3.17K | ﹤0.01% | 3908 |
|
|
2022
Q2 | $267K | Sell |
26,543
-2,400
| -8% | -$24.1K | ﹤0.01% | 3698 |
|
|
2022
Q1 | $358K | Buy |
28,943
+3,060
| +12% | +$37.9K | ﹤0.01% | 3432 |
|
|
2021
Q4 | $592K | Buy |
25,883
+7,929
| +44% | +$181K | ﹤0.01% | 3119 |
|
|
2021
Q3 | $397K | Sell |
17,954
-4,036
| -18% | -$89.2K | ﹤0.01% | 3408 |
|
|
2021
Q2 | $285K | Buy |
21,990
+7,897
| +56% | +$102K | ﹤0.01% | 3612 |
|
|
2021
Q1 | $183K | Buy |
14,093
+1,190
| +9% | +$15.5K | ﹤0.01% | 3765 |
|
|
2020
Q4 | $178K | Buy |
+12,903
| New | +$178K | ﹤0.01% | 3544 |
|
|
2017
Q2 | – | Sell |
-30,002
| Closed | -$209K | – | 2799 |
|
|
2017
Q1 | $209K | Buy |
+30,002
| New | +$209K | ﹤0.01% | 2466 |
|